Alan W Wolf, MD | |
1915 E Rezanof Dr, Kodiak, AK 99615-6602 | |
(907) 486-9580 | |
(907) 486-9586 |
Full Name | Alan W Wolf |
---|---|
Gender | Male |
Speciality | Orthopaedic Surgery |
Location | 1915 E Rezanof Dr, Kodiak, Alaska |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770514523 | NPI | - | NPPES |
200033245 | Other | AK | MEDICARE RAILROAD |
MD3399 | Medicaid | AK |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 3399 (Alaska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Alan W Wolf, MD 1915 E Rezanof Dr, Kodiak, AK 99615-6602 Ph: (907) 486-9580 | Alan W Wolf, MD 1915 E Rezanof Dr, Kodiak, AK 99615-6602 Ph: (907) 486-9580 |
News Archive
Sexually transmitted infections are the main cause of infertility in sub-Saharan Africa, where the condition often brings stigma and social consequences to women who do not have children, according to Helen Pilcher, author of a article published in the Aug. 31 issue of the journal Nature, PRI's "The World" - a production of BBC World Service, PRI and WGBH Boston - reports.
A drug described by some people as a genius pill for enhancing cognitive function provided relief to a small group of Rochester breast cancer survivors who were coping with a side effect known as chemo-brain, according to a University of Rochester Medical Center study.
Getting a flu shot this fall? Canadians scientists have found that focusing on a pretty image could alleviate the sting of that vaccine. According to a new Universit- de Montr-al study, published in the latest edition of the Proceedings of the National Academy of Sciences (PNAS), negative and positive emotions have a direct impact on pain.
The U.S. Food and Drug Administration today expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer, and it is the first time any drug has been approved to treat certain patients with metastatic breast cancer who have a "BRCA" gene mutation.
› Verified 7 days ago
Marius Henry Panzarella, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1612 Mission Rd, Kodiak, AK 99615 Phone: 907-486-5945 |